Spine Spine
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Participants undergoing posterior spinal fusion surgery (open surgery) 2)Participants who have given their own voluntary written consent (for retrospective study participants, those who can opt out of the study) 3)Participants aged 16 to 79 years at the time of consent 4)Participants weighing 30kg or more 5)Participants with ASA-PS of I to III before the start of the study
Exclusion criteria
Exclusion criteria: 1)Participants with arrhythmia 2)Participants with a history of drug hypersensitivity (propofol, remifentanil, and/or fentanyl) 3)Participants taking steroids 4)Endoscopic surgery, anterior cervical discectomy and fusion 5)Participants who the principal investigator judges inappropriate for inclusion in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraoperative remifentanil dose | — |
Secondary
| Measure | Time frame |
|---|---|
| Events during anesthesia 1)Vasoactive medication (ephedrine, phenylephrine, norepinephrine, atropine) 2)Hypotension: mean arterial pressure 140 mmHg 4)Bradycardia: heart rate 90 min-1 Intraoperative information 1)Fentanyl consumption 2)Propofol consumption 3)Stress hormone (cortisol, ACTH) levels (before surgery and at time of leaving operation room) 4)Nociception level index Post-operative information 1)Post-operative pain score (NRS) (24 hours) 2)Total dose of postoperative fentanyl (24 hours) 3)Total dose of postoperative analgesics (NSAIDs, etc.) (24 hours) 4)Serum creatinine and troponin levels (before surgery and after the postoperative day 1) | — |
Contacts
Kyushu University Hospital